Myriad's BRCA Patents Not Only Illegal, but Also Unconstitutional, ACLU Lawsuit Alleges

In the first US lawsuit of its kind, the ACLU is challenging gene patenting as an affront to First Amendment rights. Myriad Genetics, named in the lawsuit along with the USPTO and the University of Utah Research Foundation, said it plans to "vigorously defend" its BRCA patents.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.